Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing bchronic migraine in individuals with obesity. /b

MONDAY, June 30, 2025 -- For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and...

Tirzepatide and GLP-1 receptor agonists are replacing older treatments, marking a shift in how diabetes and weight loss are managed.

"Beyond the Scale" focuses on obesity as a chronic disease - urging empathy, early intervention, and evidence-based care. SINGAPORE - Media OutReach...

"Dr. Jaya Mangal, DDS, MS, is a board-certified TMJ and Orofacial Pain specialist with advanced training from Rutgers University. She is among a...

"Dr. Jaya Mangal, DDS, MS, is a board-certified TMJ and Orofacial Pain specialist with advanced training from Rutgers University. She is among a...

A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new study presented today at...

A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new study presented today at...

During an appearance on the Just Trish podcast, Lizzo admitted to using Ozempic and other GLP-1 medication at a certain point in her weight loss...

Weight-loss injections are dominating the market: Where will GLP-1 pills fit in? Glucagon-like peptide-1 (GLP-1) medications have emerged as powerful...